Kallam Anji Reddy
Award Name : Padma Bhushan
Year of Award : 2011
Award for : Business & management
Location : Govindapuram,Chilakaluripet,Guntur, Andhra Pradesh, India
Kallam Anji Reddy was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy's Laboratories, which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group, established 1996. The Government of India honoured him with the Padma Shri in 2001 and later with the Padmabhushan for his contribution to the Indian pharmaceutical industry. He was a member of the Indian Prime Minister's Council on Trade and Industry. He was born in 1940 in Guntur district, Andhra Pradesh, India. Dr Kallam Anji Reddy did his B.Sc in Pharmaceuticals and Fine chemicals from Bombay University and subsequently completed his PhD in Chemical Engineering from National Chemical Laboratory, Pune, in 1969. Dr. K. Anji Reddy served in PSU Indian Drugs and Pharmaceuticals Limited from 1969 to 1975. Dr. Reddy was the founder-Managing Director of Uniloids Ltd from 1976 to 1980 and Standard Organics Limited from 1980 to 1984.
In 1984, Dr. K. Anji Reddy founded Dr. Reddy's Laboratories and soon the company established new benchmarks in the Indian Pharmaceutical industry. Dr. Reddy's Laboratories transformed Indian bulk drug industry from import-dependent in mid-80s to self-reliant in mid-90s and finally into the export-oriented industry that it is presently. In 1993, Dr. Reddy's became the first company to take up drug discovery research in India and in April 2001 it became the first non-Japanese Asian pharmaceutical company to list on NYSE. By the end of fiscal year 2005, Dr. Reddy's Laboratories was India's second largest pharmaceutical company and the youngest among its peer group. Dr. K. Anji Reddy is also a philanthropist. He is the founder-Chairman of Dr. Reddy's Foundation for Human & Social Development, a social arm of Dr. Reddy's, which acts as a catalyst of change to achieve sustainable development.